Says Nanoviricides News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Says nanoviricides. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Says Nanoviricides Today - Breaking & Trending Today

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United States , Mpox Clade , Nanoviricides Inc , Agency Announcement , Development Authority , News Network , Theracour Pharma Inc , Biomedical Advanced Research , Novel Broad Spectrum Antiviral , Activity Against , Strong Orthopoxvirus Activity Relevant , Both Sexual , Inhalation Modes , Says Nanoviricides , Lethally Infected Mice , Ectromelia Virus , Footpad Infection , Broad Agency Announcement , Nanoviricides Platform , Human Immunodeficiency Virus , Hepatitisb Virus , Hepatitisc Virus , Herpes Simplex Virus , Varicella Zoster Virus , Asian Bird Flu Virus , Japanese Encephalitis ,

PRESS RELEASE: NanoViricides, Inc.: Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.'s President, Dr. Anil Diwan

Message :
Required fields
DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous
NanoViricides, Inc.: Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus
Variants, Says NanoViricides, Inc. s President, Dr. Anil Diwan
2021-01-27 / 12:15
The issuer is solely responsible for the content of this announcement.
=
Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says
NanoViricides, Inc. s President, Dr. Anil Diwan
SHELTON, CT / ACCESSWIRE / January 27, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the Company ) a global leader
in the development of highly effective broad-spectrum antiviral therapies based on a novel nanomedicines platform,
today discusses the current developments in the COVID-19 pandemic and the Company s exciting accomplishments related to ....

South Africa , United States , United Kingdom , City Of , South African , Los Angeles , Eli Lilly , Nanoviricides Inc , Miscellaneous Nanoviricides Inc , Says Nanoviricides , Anil Diwan , President Biden , Dow Jones , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , லாஸ் ஏஞ்சல்ஸ் , எலி லில்லி , அனில் திவான் , ப்ரெஸிடெஂட் பிடென் , டோ ஜோன்ஸ் ,